NCT03584321View on ClinicalTrials.gov

Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease

CompletedOBSERVATIONAL

Enrollment

1,600

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

July 11, 2018

Study Completion Date

July 11, 2018

Conditions

Non-Obstructive Coronary Artery Disease

Trial Locations (1)

64293

Please Contact the Merck KGaA Communication Center, Darmstadt

All Listed Sponsors

collaborator

Merck Serono Co., Ltd., China

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT03584321 - Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease | Biotech Hunter | Biotech Hunter